Stereotactic Radiation Feasible for Oligometastatic Cancer

TUESDAY, Feb. 26, 2019 -- Stereotactic ablative radiation therapy (SABR) for recurrent oligometastatic cancer is a feasible and tolerable treatment option, according to a phase 2 study published in the January issue of the International Journal of...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news